Piper Sandler bullish on Colgate-Palmolive with $121 target

Published 23/09/2024, 21:28
Piper Sandler bullish on Colgate-Palmolive with $121 target

On Monday, Piper Sandler initiated coverage on Colgate-Palmolive Company (NYSE:NYSE:CL) with an Overweight rating and set a price target of $121.00. The firm highlighted Colgate-Palmolive's transition to a more normalized growth profile, which is considered favorable compared to its industry peers. The analyst noted that the company's volumes are maintaining well and are expected to show further improvement after the second half of the year, which presents tougher comparisons.

According to Piper Sandler, Colgate-Palmolive does not require significant promotional activities to sustain its growth. This aspect is likely to contribute positively to the company's margin progression and robust cash generation. The firm anticipates that these factors will support a higher valuation multiple for the stock.

The analysis by Piper Sandler suggests that Colgate-Palmolive is well-positioned for continued success, based on its current performance and market conditions. The company's ability to maintain volume growth without heavy promotions is seen as a key driver for its future financial health.

The Overweight rating indicates that Piper Sandler expects Colgate-Palmolive's stock performance to outperform the average return of the stocks the firm covers over the next 12 to 18 months. The $121.00 price target reflects a potential upside from the current trading price, signaling confidence in the company's value proposition and earnings potential.

Investors and market watchers will likely monitor Colgate-Palmolive's performance in the coming months to see if the company can meet the expectations set by Piper Sandler's coverage initiation. The focus will be on volume trends and margin improvements as indicators of the company's financial trajectory.

In other recent news, Colgate-Palmolive reported robust growth in the second quarter of 2024, returning to mid-single-digit volume growth and expanding gross margins. The company's success has been attributed to innovative product launches, strategic marketing across various price points, and strong execution in developing markets.

Wells Fargo has downgraded Colgate-Palmolive from Equal Weight to Underweight, citing potential modest downside potential and a possible reversion in the company's toothpaste market share. Meanwhile, TD Cowen and Evercore ISI have increased their price targets on Colgate-Palmolive to $115 and $112 respectively, while maintaining Buy and Outperform ratings.

Jefferies has also increased its price target for Colgate-Palmolive to $101, albeit with caution regarding the sustainability of the company's performance. The company's recent developments also include a potential slowdown in gross margin expansion and relative underperformance compared to its peers, as suggested by Wells Fargo's analysis.

Despite these challenges, Colgate-Palmolive continues to maintain solid volume growth in various markets, particularly in Brazil and Mexico. As the company navigates these recent developments, it plans to continue investing in advertising and innovation for long-term growth.


InvestingPro Insights


In light of Piper Sandler's optimistic outlook on Colgate-Palmolive Company, it's worthwhile to consider some key metrics and InvestingPro Tips that could further inform investor decisions. With a robust market capitalization of $84.42 billion and a P/E ratio standing at 29.93, Colgate-Palmolive appears to be valued significantly by the market. The company's gross profit margin is particularly impressive at 59.7%, showcasing its ability to maintain profitability. Additionally, the firm's commitment to shareholder returns is evident, having raised its dividend for 54 consecutive years, a testament to its consistent performance and financial stability.

InvestingPro Tips highlight that Colgate-Palmolive is trading at a low P/E ratio relative to near-term earnings growth, which could signal that the stock is undervalued given its growth prospects. Moreover, the company's stock generally trades with low price volatility, offering potential stability for investors. For those seeking more comprehensive analysis, there are over 10 additional InvestingPro Tips available, which can be accessed for Colgate-Palmolive at https://www.investing.com/pro/CL.

These insights, combined with Piper Sandler's coverage, paint a picture of a company with strong fundamentals and a promising outlook, possibly supporting a higher valuation multiple as anticipated by the firm.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.